X
Sosei shares tank after safety issue with Alzheimer’s drug
https://pharmaphorum.com/news/sosei-shares-tank-after-safety-issue-with-alzheimers-drug/
Allergan
FDA rejects Allergan’s fibroids drug, citing liver safety concerns
European regulators have already restricted use
Mylan to develop Botox biosimilar with Revance
Mylan takes aim at Allergan’s off-patent blockbuster
Allergan and Gedeon Richter set to expand use of bipolar drug
Companies want Vraylar as option bipolar depression
New Teva CEO axes R&D chief Hayden in boardroom shakeup
R&D chief Michael Hayden to leave at year end.
Judge throws out Allergan patents, criticises Native American tribe deal
Federal court throws out patents on Restasis
US lawmaker moves to block Allergan patent deal with tribe
Senator Claire McCaskill says deal exploits a “brazen loophole”.
